Columbian officials accidentally reveal details on Big Pharma’s immunity for adverse reactions to COVID vaccines
Besides the eye-watering costs, the nation agreed to indemnify the manufacturers from any legal responsibility for adverse events arising from the use of their products.
(LifeSiteNews) – Officials in Colombia accidentally published contracts from both Pfizer/BioNTech and AstraZeneca, detailing the multimillion-dollar deals and indemnification agreements struck between the South American nation and the pharmaceutical giants to import around 25 million combined doses of their COVID-19 vaccines.
While attempting to transfer the confidential information to a regional court following a tutelage filing, Colombia’s Council of State, the supreme judicial authority in the country, mistakenly disclosed contracts signed between the Colombian government and the drug manufacturers on its publicly accessible judicial information system, an RT news report revealed.
Though the mistake was quickly discovered by the government and the documents removed from public access, the Colombia-based non-profit Anticorruption Institute was able to access and copy the information, and later published the leaked documents on its own website “to defend transparency and in a bid to safeguard the fundamental right of access to public information,” they argued.
The 132-page file details the contractual agreement established between the Colombian government and the two pharmaceutical companies, with AstraZeneca’s contract being signed on December 16, 2020, and Pfizer’s on February 2, 2021.
Colombian officials agreed to pay AstraZeneca $6 per dose, ordering a total of 9,984,000 shots from the Oxford-based operation and costing $59,904,000. Pfizer negotiated $12 per dose of their mRNA jab, selling the Colombians 15,000,570 shots totalling $180,006,840. All told, the Colombian government shelled out a hefty $239,910,840 for 24,984,570 doses of COVID-19 vaccines, corresponding to 12,492,285 citizens (around 25 percent of the population) being able to become “fully vaccinated” against the virus.